Please refer attachement

ssebnl Emmessar Biotech & Nutrition Ltd ‘ EMMESSAR BIOTECH & NUTRITION LIMITED 29, Kamer Building, 4th floor, 38, Cawasji Patel Street, Fort, Mumbai — 400 001 Tel: 022-35661373 / 35664530 Email: enquiries@ebnl.org Website: www.ebnl.org Investors Grievance Email: investors@ebnLorg CIN No. L24110MH1992PLC065942 Date: August 07, 2026 The Manager Listing Department, Bombay Stock Exchange Limited, * P. J. Tower, Dalal Street, Mumbai - 400 001 R-ef:S ecuCodre Nio0.t524y768 Sub: Outcome of Board Meeting The Board of Directors at their meeting held today i.e. August 07, 2026 has transacted the following items of business: 1. Unaudited Financial Results for the Quarter ended June 30, 2026: Pursuant to Regulation 33(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are forwarding herewith a copy of Unaudited Financial Results for the Quarter ended 30.06.2026. The above results have been reviewed by the Audit Committee and approved by the Board of Directors of the Company at their meeting held on 07.08.2026 (i.e today). We also enclose “Limited Review Report" dated 07.08.2026, issued by Statutory Auditors, M/s. V. Nagarajan & Co., Chartered Accountant(s), FRN No.: 004879N, in respect of Unaudited Financial Results for the Quarter ended 30.06.2026. The results are attached at “Annexure A”. 2. ral H The 34 Annual General Meeting of the Company is scheduled to be held on Tuesday September 29, 2025 at 10:30 a.m. through video conferencing pursuant to MCA General Circular Nos. 14/2020, 17/2020, 20/2020, 02/2021, 21/2021, 02/2022, 10/2022, 09/2023, 09/2024 and 03/2025; dated April 8, 2020, April 13, 2020, May 5, 2020, January 13, 2021, December 14, 2021, May 5, 2022, December 28, 2022, September 25, 2023, September 19, 2024 and September 22, 2025 respectively (*MCA Circulars”) (hereinafter collectively referred to as “MCA Circulars”) and Circular No. SEBI/HO/ CFD/CMD1/CIR/P/2020/79 dated May 12, 2020, Circular No. SEBI/HO/CFD/ CMD2/CIR/P/2022/62 dated May 13, 2022, Circular No. SEBI/HO/ CFD/PoD-2/P/CIR/2023/4 dated January 5, 2023, Circular No. SEBI/HO/CFD/CFD-PoD-2/P/CIR/2023/167 dated October 7, 2023 and Circular No. SEBI/HO/CFD/CFD-PoD-2/P/CIR/2024/133 dated October 3, 2024 (“SEBL circulars”). In compliance with these MCA and SEBI Circulars, there has been certain relaxations from compliance with certain provisions of the SEBI (Listing Obligations and Disclosure ~Requirements) Regulations, 2015 (“Listing Regulations”), issued in this behalf. In compliance with these MCA and SEBI Circulars, provisions of the Companies Act, 2013 (the “Act”) and the Listing Regulations, the ensuing 34t AGM of the Com 0 pany Regd. Office & Factory: Plot No. T-3/2, MIDC Area, Taloja— 410208. Dist. Raigad. M4 2 Email: enquiries@ebnl.org Website: www.ebnl.org <ebnl Emmessar Biotech & Nutrition Ltd ‘ EMMESSAR BIOTECH & NUTRITION LIMITED 29, Kamer Building, 4th floor, 38, Cawasji Patel Street, Fort, Mumbai — 400 001 Tel: 022-35661373 / 35664530 Email: enquiries@ebnl.org Website: www.ebnl.org Investors Grievance Email: investors@ebnl.org CIN No. 1.24110MH1992PLC065942 will be conducted through VC/ OAVM facility, which does not require physical presence of members at a common venue. The deemed venue for the 34" AGM shall be the Registered Office of the Company. 3. E voting and Cut-off date: In compliance with the provisidns of Section 108 of the Companies Act, 2013, read with Rule 20 Companies (Management and Administration) Rules as amended up to date and Regulation 44 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, the Company has decided to provide the facility to members to exercise their right to vote at the Annual General Meeting (AGM) by electronic means and the business may be transacted through e-Voting services provided by MUFG Intime India Private Limited formerly known as Link Intime India Pvt. Ltd (MUFG). The cutoff date for the limited purpose of remote e-voting is September 22, 2026. The remote e-voting period will commence on Saturday, September 26, 2026 at 09:00 A.M. IST and end on Monday, September 28, 2026 at 5:00 P.M IST. During this period shareholders of the Company, holding shares either in physical form or in dematerialised form, as on cut-off date i.e. Tuesday, September 22, 2026, may cast their vote electronically. The Meeting commenced at 12:15 pm and concluded at 13:40 p.m. Kindly take the above on record. For e EMMESSAR BI OTECH & NUTRITION LIMITED M S Raghavan Ayyangar (Managing Director) Encl: As above Regd. Office & Factory: Plot No. T-3/2, MIDC Area, Taloja — 410208. Dist. Raigad. Maharashtra. Email: enquiries@ebnl.org Website: www.ebnl.org V NAGARAJAN CO. INDI A Chartered Accountants Limited Review Report on Unaudited Financial Resultsof EmmessarBiotech & Nutrition Limited for the Quarterended 30th June 2026 pursuant to Regulation33ofSecurities and Exchange Board of India(Listing Obligations and DisclosureRequirements) Regulations, 2015,asamended TotheBoard ofDirectors of EmmessarBiotech& Nutrition Limited 1. We have reviewed the accompanying Statementof unaudited financial results of Emmessar Biotech & Nutrition Limited ("the Company") for the quarter ended 30th June 2026,("The Statement"). 2. This Statement, whichisthe responsibility ofthe Company's Management and approved bythe Board of Directors, has been preparedin accordancewith the recognition and measurement principles laid down in Indian AccountingStandard34 "Interim Financial Reporting" ("Ind AS 34"), prescribed underSection 133ofthe Companies Act,2013 read with relevant rules issued thereunderand otheraccounting principles generally acceptedin Indiaand incompliancewith Regulation 33of Securities and Exchange Board of India(Listing Obligations and Disclosure Requirements)Regulations, 2015,asamended ("Listing Regulations"). Ourresponsibility is to issueareport onthe statement basedon our review. 3. We conducted ourreview in accordance with theStandards on Review Engagements (SRE) 2410, 'Reviewon lnterim Financial Information Performed by the Independentauditor of the Entity issued bythe Institute of Chartered Accountantsof India. These standardsrequire that we plan and perform the review to obtain moderate assurance as towhether the Statement is freeofmaterial misstatement. A review islimited primarily toenquiries oftheCompanypersonnel and analytical procedures applied to financial data and thus provide less assurance than an We audit. have not performedan audit and accordingly, wedo not expressan audit opinion. 4 Based on ourreviewconducted asabove,nothing has come to ourattention that causes usto believe that theaccompanying statementof unauditedfinancial results prepared in accordance with applicable accountingstandards and other recognizedaccountingpractices and policies has notdisclosed theinformation required to bedisclosed in termsof Regulation33 oftheSEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 including the manner in which itisto be disclosed, orthat itcontains any material misstatement. ForV Nagarajan & Co. Chartered Accountants ICAIFirm Regn.No.004879N (cid:26)ARA 004879N TEREDACO ShankarCherekupally Partner Place: Hyderabad MembershipNo.252304 Date: 07hAugust,2026 UDIN:26252304YBATDC7429 C-1120-1121, 11th Floor,TowerCKU Noida One Block-B, Sector-62, Noida-201 309, Uttar Pradesh, India. Ph:91-124-407 8742--44| 6-3-1191-1196, 2ndFloor,Brij Tarang Towers, Kundanbagh Colony, Begumpet,Hyderabad, Telangana, 500016, IndiaPh:-9395328742 E-mail:contact@vnc.co.in| website:-www.vnc.co.in page 1 of1 6 -3 -1 & V N A G A R A J A N C O . C A - - . . .A R C IN D I A C h a r te r e d A c c o u n ta n t s & R e v ie w L im ite d o n U n a u d it e d F in a n c ia l R e s u lt s o f E m m e s s a r B io t e c h N u tr it io n R e p o r t L im it e d fo r th e Q u a r te r e n d e d 3 0 " J u n e 2 0 2 6 to R e g u la t io n 3 3 o f S e c u r it ie s a n d p u r s u a n t B o a r d o f a n d D is c lo s u r e R [Showing first 8,000 characters — download PDF for full document]